EARNINGS PER SHARE (Tables)

3 Months Ended

6 Months Ended

Jun. 30, 2012

Jun. 30, 2012

SCHEDULE OF EPS- BASIC AND DILUTED [Table Text Block]

Weighted average shares:
		For the three months ended
		June 30, 2012		June 30, 2011
Basic		25,875,164		24,632,774
Effect of dilutive common share equivalents:
Diluted effect of the Notes		-		903,846
Diluted effect of warrants		311,200		598,113
Diluted effect of stock option		440,796		603,546
Diluted		26,627,160		26,738,279
Net income per share of common stock - basic	$	0.50	$	0.67
Net income per share of common stock - diluted	$	0.46	$	0.28

Weighted average shares:
		For the six months ended
		June 30, 2012		June 30, 2011
Basic		25,738,145		24,492,728
Effect of dilutive common share equivalents:
Diluted effect of the Notes		-		1,038,674
Diluted effect of warrants		390,507		631,911
Diluted effect of stock option		453,172		639,370
Diluted		26,581,824		26,802,683
Netincome per share of common stock - basic	$	1.00	$	0.94
Net income per share of common stock - diluted	$	0.90	$	0.53

SCHEDULE OF EPS RECONCILIATION [Table Text Block]

		For the three months ended
		June 30, 2012			June 30, 2011
Numerator used in basic net income per share of common stock:
Net income attributable to China Biologic Products, Inc.	$	12,838,771		$	16,599,705
Interest on the Notes		-			2,077,028
Change in fair value of embedded conversion option in the Notes		-			(5,781,624	)
Change in fair value of warrants		(559,758	)		(5,393,760	)
Numerator used in diluted net income per share of common stock	$	12,279,013		$	7,501,349

		For the six months ended
		June 30, 2012			June 30, 2011
Numerator used in basic net income per share of common stock:
Net income attributable to China Biologic Products, Inc.	$	25,796,077		$	22,908,680
Interest on the Notes		-			3,580,167
Change in fair value of embedded conversion option in the Notes		-			(6,289,661	)
Change in fair value of warrants		(1,769,140	)		(5,907,588	)
Numerator used in diluted net income per share of common stock	$	24,026,937		$	14,291,598